Skip to content

A Prospective Cohort Study on the Treatment of Pediatric Alopecia Areata with Jiawei Shaoyao Gancao Decoction (Paeonia lactiflora and Glycyrrhiza uralensis)

Integration of Traditional Chinese and Western Medicine for Prevention and Treatment of Hair and Scar Disorders: Leadership Talent Training Program

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2026001381
Enrollment
Unknown
Registered
2026-05-26
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Androgenetic alopecia

Interventions

Exposure group:Jiawei Shaoyao Gancao Decoction
Control Group:Shaoyao Gancao Decoction

Sponsors

China-Japan Friendship Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1) aged between 6 and 18 years 2) meeting the diagnostic criteria for alopecia areata 3) meeting the disease staging criteria for the stable phase 4) meeting the diagnostic criteria for the liver qi stagnation and spleen deficiency pattern 5) voluntarily participating in this study, able to adhere to medication and follow-up, and willing to sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Duration of alopecia areata exceeds two years; 2. Pregnancy or lactation; 3. Received systemic treatment for hair loss within the past three months or topical treatment for hair loss within the past one month; 4. Severe heart, liver, kidney diseases, mental disorders, or other skin diseases except alopecia areata; 5. Patients with a clear history of schizophrenia, or history of alcohol or substance abuse or dependence; 6. Any other conditions deemed unsuitable for participation in this trial by the investigator.

Design outcomes

Primary

MeasureTime frame
Efficient;

Secondary

MeasureTime frame
SALT Score Change Value;Changes in Liver Qi Stagnation and Spleen Deficiency Syndrome Scores Before and After Treatment;Changes in the Anxiety and Depression Scale;

Countries

China

Contacts

Public ContactYang Dingquan

China-Japan Friendship Hospital

ydqlx@163.com13901218671

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Jun 11, 2026